These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28921531)

  • 1. A naive Bayes algorithm for tissue origin diagnosis (TOD-Bayes) of synchronous multifocal tumors in the hepatobiliary and pancreatic system.
    Jiang W; Shen Y; Ding Y; Ye C; Zheng Y; Zhao P; Liu L; Tong Z; Zhou L; Sun S; Zhang X; Teng L; Timko MP; Fan L; Fang W
    Int J Cancer; 2018 Jan; 142(2):357-368. PubMed ID: 28921531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying the clonal origin of synchronous multifocal tumors in the hepatobiliary and pancreatic system using multi-omic platforms.
    Jiang W; Ding Y; Shen Y; Fan L; Zhou L; Li Z; Zheng Y; Zhao P; Liu L; Tong Z; Fang W; Wang W
    Oncotarget; 2017 Jan; 8(3):5016-5025. PubMed ID: 28008139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TOD-CUP: a gene expression rank-based majority vote algorithm for tissue origin diagnosis of cancers of unknown primary.
    Shen Y; Chu Q; Yin X; He Y; Bai P; Wang Y; Fang W; Timko MP; Fan L; Jiang W
    Brief Bioinform; 2021 Mar; 22(2):2106-2118. PubMed ID: 32266390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial neural networks for multi-omics classifications of hepato-pancreato-biliary cancers: towards the clinical application of genetic data.
    Bagante F; Spolverato G; Ruzzenente A; Luchini C; Tsilimigras DI; Campagnaro T; Conci S; Corbo V; Scarpa A; Guglielmi A; Pawlik TM
    Eur J Cancer; 2021 May; 148():348-358. PubMed ID: 33774439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of potential biomarkers for diagnosis of pancreatic and biliary tract cancers by sequencing of serum microRNAs.
    Kim K; Yoo D; Lee HS; Lee KJ; Park SB; Kim C; Jo JH; Jung DE; Song SY
    BMC Med Genomics; 2019 May; 12(1):62. PubMed ID: 31096984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational Profiling Can Establish Clonal or Independent Origin in Synchronous Bilateral Breast and Other Tumors.
    Bao L; Messer K; Schwab R; Harismendy O; Pu M; Crain B; Yost S; Frazer KA; Rana B; Hasteh F; Wallace A; Parker BA
    PLoS One; 2015; 10(11):e0142487. PubMed ID: 26554380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers.
    Kojima M; Sudo H; Kawauchi J; Takizawa S; Kondou S; Nobumasa H; Ochiai A
    PLoS One; 2015; 10(2):e0118220. PubMed ID: 25706130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA-Seq accurately identifies cancer biomarker signatures to distinguish tissue of origin.
    Wei IH; Shi Y; Jiang H; Kumar-Sinha C; Chinnaiyan AM
    Neoplasia; 2014 Nov; 16(11):918-27. PubMed ID: 25425966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining the origin of synchronous multifocal bladder cancer by exome sequencing.
    Acar Ö; Özkurt E; Demir G; Saraç H; Alkan C; Esen T; Somel M; Lack NA
    BMC Cancer; 2015 Nov; 15():871. PubMed ID: 26553077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of multiple types of pancreatico-biliary tumors by molecular analysis of clinical specimens.
    Gress TM; Kestler HA; Lausser L; Fiedler L; Sipos B; Michalski CW; Werner J; Giese N; Scarpa A; Buchholz M
    J Mol Med (Berl); 2012 Apr; 90(4):457-64. PubMed ID: 22119958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Expression Analysis in RNA-Seq by a Naive Bayes Classifier with Local Normalization.
    Dou Y; Guo X; Yuan L; Holding DR; Zhang C
    Biomed Res Int; 2015; 2015():789516. PubMed ID: 26339642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical characteristics and imaging diagnosis of early cancer in the hepatobiliary and pancreatic region].
    Mizumoto R; Ogura Y; Matsuda S
    Gan No Rinsho; 1988 Aug; 34(10):1342-8. PubMed ID: 3050200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatobiliary and Pancreatic neoplasms in patients with McCune-Albright syndrome.
    Gaujoux S; Salenave S; Ronot M; Rangheard AS; Cros J; Belghiti J; Sauvanet A; Ruszniewski P; Chanson P
    J Clin Endocrinol Metab; 2014 Jan; 99(1):E97-101. PubMed ID: 24170100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical Typing of Adenocarcinomas of the Pancreatobiliary System Improves Diagnosis and Prognostic Stratification.
    Fernández Moro C; Fernandez-Woodbridge A; Alistair D'souza M; Zhang Q; Bozoky B; Kandaswamy SV; Catalano P; Heuchel R; Shtembari S; Del Chiaro M; Danielsson O; Björnstedt M; Löhr JM; Isaksson B; Verbeke C; Bozóky B
    PLoS One; 2016; 11(11):e0166067. PubMed ID: 27829047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of pancreatico-biliary malignancy: detection of gene mutations in plasma and stool.
    Mulcahy H; Farthing MJ
    Ann Oncol; 1999; 10 Suppl 4():114-7. PubMed ID: 10436800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a symptom index for advanced hepatobiliary and pancreatic cancers: the National Comprehensive Cancer Network Functional Assessment of Cancer Therapy (NCCN-FACT) Hepatobiliary-Pancreatic Symptom Index (NFHSI).
    Butt Z; Parikh ND; Beaumont JL; Rosenbloom SK; Syrjala KL; Abernethy AP; Benson AB; Cella D
    Cancer; 2012 Dec; 118(23):5997-6004. PubMed ID: 22605658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of DNA copy number changes detected by comparative genomic hybridization in malignancies of the liver, biliary tract and pancreas.
    Shiraishi K; Okita K; Kusano N; Harada T; Kondoh S; Okita S; Ryozawa S; Ohmura R; Noguchi T; Iida Y; Akiyama T; Oga A; Fukumoto Y; Furuya T; Kawauchi S; Sasaki K
    Oncology; 2001; 60(2):151-61. PubMed ID: 11244331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancers of the pancreas and hepatobiliary system.
    Sauerland C; Engelking C; Wickham R; Pearlstone DB
    Semin Oncol Nurs; 2009 Feb; 25(1):76-92. PubMed ID: 19217507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of molecular imaging to differentiate liver metastasis of colorectal cancer metastasis from neuroendocrine tumor origin.
    Desai K; Watkins J; Woodward N; Quigley AM; Toumpanakis C; Bomanji J; Caplin M
    J Clin Gastroenterol; 2011 Jan; 45(1):e8-11. PubMed ID: 20861802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of an organoid bank of biliary tract and pancreatic cancers and its application for personalized therapy and future treatment.
    Saito Y
    J Gastroenterol Hepatol; 2019 Nov; 34(11):1906-1910. PubMed ID: 31264257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.